company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,377911.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,377911.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,377911.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,802053.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1797429.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2599482.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2221571.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6656.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6656.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2214915.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8230.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2223145.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2223145.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2223145.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5600000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5600000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5607022.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:38:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,598252.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,598252.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,598252.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1046608.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4952260.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5998868.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5400616.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,241316.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3555.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-237761.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5638377.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5638377.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5638377.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5638377.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14500000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14500000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14599612.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q1,2013-01-01,2013-03-31,2014-05-05 16:29:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,643264.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,643264.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,643264.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,903406.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7787901.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8691307.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8048043.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,231756.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2408.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-229348.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8277391.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8277391.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8277391.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8277391.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14800000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14800000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14690942.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q2,2013-04-01,2013-06-30,2014-08-12 16:18:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,667955.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,667955.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,667955.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1295571.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4157742.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5453313.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4785358.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,131888.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5626.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-126262.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4911620.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4911620.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4911620.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4911620.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17500000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17500000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17527774.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:28:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,827531.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,827531.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,827531.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2730691.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6129675.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8860366.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8032835.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8003.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18028.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10025.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8022810.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8040810.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8040810.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8040810.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17260768.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10818.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10818.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10818.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-65.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10883.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10883.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10883.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10883.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q1,2013-04-01,2013-06-30,2013-08-14 19:16:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,219238.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,219238.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,219238.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2121120.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2709702.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4830822.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4611584.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2032.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,80077.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,78045.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4533539.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4533539.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4533539.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4533539.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29273357.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 16:31:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,124414.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,124414.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,124414.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2581685.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4046335.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6628020.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6503606.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,88099.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,88099.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6415507.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6415507.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6415507.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6415507.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29379156.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:31:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,233649.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,233649.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,233649.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5624056.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14470308.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20094364.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19860715.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4976.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,135760.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,130784.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19729931.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1600.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19731531.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19731531.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19731531.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28700000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28700000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28650067.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3315.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3315.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3315.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3771628.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18632427.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22404055.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22400740.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,113916.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,113916.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22286824.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22286824.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22286824.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22286824.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30775287.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:32:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57390.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57390.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57390.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3985797.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17762518.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21748315.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21690925.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,179607.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,179607.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21511318.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21511318.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21511318.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21511318.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35002819.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:31:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3891744.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28457631.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32349375.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32349375.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,188892.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,188892.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32160483.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32160483.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32160483.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32160483.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35320046.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:16:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30659.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30659.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30659.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6538117.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22865498.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29403615.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29372956.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,540040.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,540040.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28832916.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1600.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28834516.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28834516.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28834516.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.67
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.67
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36069237.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.67
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5064233.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23433620.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28497853.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28497853.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,656404.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,656404.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27841449.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27841449.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27841449.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27841449.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43500000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43500000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43193857.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:32:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,228445.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,228445.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,228445.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6471804.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25300668.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31772472.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31544027.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,709573.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,709573.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30834454.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30834454.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30834454.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30834454.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43400000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43400000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43239708.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q2,2016-04-01,2016-06-30,2016-08-04 16:31:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4362.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4362.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4362.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6270528.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23918232.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30188760.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30184398.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12260.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,763949.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,751689.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29432709.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,832618.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30265327.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30265327.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30265327.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43253429.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:16:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,97895.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,97895.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,97895.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6951498.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21179010.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28130508.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28032613.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24521.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,805151.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,780630.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27251983.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,233055.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27485038.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27485038.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27485038.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43240188.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,95287.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,95287.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,95287.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6310486.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21538958.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27849444.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27754157.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,822175.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,822175.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26931982.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1600.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26933582.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26933582.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26933582.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43400000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43400000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43385605.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:06:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,114741.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,114741.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,114741.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6254616.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12478638.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18733254.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18618513.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,857809.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,857809.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17760704.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17760704.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17760704.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17760704.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43419798.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 16:17:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30754.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30754.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30754.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5317577.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18472372.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23789949.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23759195.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,884763.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,884763.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22874432.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4016.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22870416.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22870416.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22870416.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43200000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43424387.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:32:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5055.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5055.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5055.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5784278.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26929041.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32713319.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32708264.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1441117.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1441117.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31267147.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1058435.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30208712.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30208712.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30208712.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46100000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46100000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46181926.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6381228.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30702998.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37084226.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37084226.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1604148.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1604148.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35480078.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35480078.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35480078.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35480078.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54600000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54600000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54676175.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:17:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6728987.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32439270.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39168257.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39168257.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1793474.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1793474.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37374783.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1600.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37376383.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37376383.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37376383.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55000000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54696698.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:16:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7972329.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35419016.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43391345.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43391345.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1868431.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1868431.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41522914.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41522914.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41522914.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41522914.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54600000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.76
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54600000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.76
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54708065.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 08:17:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.76
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9017311.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33605629.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42622940.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42622940.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1874904.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1874904.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40748036.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40748036.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40748036.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40748036.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54600000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54600000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54707865.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11704984.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24990856.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36695840.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36695840.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1860077.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1860077.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34835763.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34835763.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34835763.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34835763.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55113226.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:32:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15442650.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23728464.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39171114.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39171114.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1731550.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1731550.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37439564.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1600.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37441164.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37441164.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37441164.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55100000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55100000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55145901.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:16:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15036444.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21339792.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36376236.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36376236.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1513837.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1513837.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34862399.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34862399.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34862399.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34862399.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55300000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55207400.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 08:17:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60613.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60613.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60613.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22763547.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19065726.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41829273.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41768660.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1185808.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1185808.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40582852.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40582852.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40582852.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40582852.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55100000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55100000.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55186206.0
Intra-Cellular Therapies Inc,ITCI,,0001567514,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
